Rhythm Pharmaceuticals Cash Flow Statement (2016-2026) | RYTM

Cash Flow Statement Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-35.39M-38.31M-53.83M-55.33M-47.42M-40.86M-42.49M-52.18M-46.70M-44.16M-41.63M-141.37M-32.28M-43.64M-43.33M-49.52M-46.59M-52.90M-47.51M-55.59M
Share-based Compensation (Quarter)
5.67M5.27M4.68M4.61M5.14M4.80M5.29M6.38M8.89M8.61M8.67M7.77M10.36M11.00M10.56M28.74M18.81M19.27M8.46M
Deferred Taxes (Quarter)
-5.02M-8.99M
Cash from Operations (Quarter)
-31.84M-40.16M-40.47M-53.63M-38.81M-46.99M-34.00M-36.43M-41.09M-29.25M-29.38M-40.74M-29.08M-25.21M-18.84M-40.35M-23.31M-26.62M-25.39M-44.19M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
3.15M4.02M4.01M5.91M5.24M5.45M5.41M5.82M4.74M4.62M4.58M
Depreciation & Amortization (CF) (Quarter)
0.32M0.32M
Change in Working Capital
Change in Receivables (Quarter)
0.60M2.90M1.89M5.71M0.71M0.33M-0.17M2.90M1.71M-0.79M-0.69M7.83M6.60M-6.17M8.11M
Change in Inventory (Quarter)
-0.01M1.23M2.57M0.69M1.58M0.86M-0.12M3.49M1.90M4.85M0.57M-0.48M2.45M4.93M3.09M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
5.67M5.99M12.92M-0.05M-1.55M-12.57M15.71M5.17M0.66M4.09M4.86M-1.25M0.48M7.51M15.18M-3.63M13.26M11.02M1.25M-5.62M
Other Working Capital Changes (Quarter)
3.02M-2.96M4.93M-0.95M-1.75M3.18M-0.97M-0.01M-0.14M-2.73M2.42M-2.71M0.11M0.18M-1.29M0.19M0.49M
Investing Activities
Capital Expenditures (Quarter)
0.25M10.27M1.28M0.13M0.06M4.65M-4.56M0.10M-1.22M-0.54M0.00M-1.20M-1.05M-0.91M3.16M-0.10M-5.42M5.24M0.68M-0.43M
Change in Acquisitions & Divestments (Quarter)
83.70M156.66M69.05M112.13M51.00M61.48M59.64M92.67M124.50M74.50M63.29M70.05M57.75M45.30M87.53M58.33M80.99M61.50M51.65M99.25M
Cash from Investing Activities (Quarter)
13.53M62.78M7.25M72.52M35.98M-39.70M-40.77M18.46M48.19M-94.96M22.64M30.05M-8.56M-90.82M21.16M24.81M54.03M-246.35M30.35M57.05M
Financing Activities
Other financing activities (Quarter)
3.46M-3.23M0.40M3.46M-3.24M0.55M0.34M1.58M-2.47M6.35M1.40M-6.49M7.63M0.85M4.82M5.49M177.50M1.25M
Cash from Financing Activities (Quarter)
0.38M0.41M0.10M0.40M37.50M158.56M17.36M-0.13M-0.96M73.04M2.42M4.24M146.18M2.49M38.33M32.50M-0.89M189.30M-2.95M-5.40M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-0.01M14.14M-48.88M34.03M154.62M-188.66M
Additional items
Exchange Rate Effect (Quarter)
0.09M-0.11M0.08M-0.19M-0.07M-0.30M-0.60M0.98M-0.00M-0.28M0.30M0.06M0.45M
Change in Cash (Quarter)
-17.93M23.03M-33.12M19.29M34.67M71.88M-57.41M-18.02M6.02M-51.09M-4.51M-6.52M108.24M-114.14M41.62M16.96M29.55M-83.36M2.07M7.92M
Free Cash Flow (Quarter)
-32.09M-50.43M-41.75M-53.76M-38.87M-51.64M-29.44M-36.53M-39.87M-28.71M-29.39M-39.55M-28.02M-24.31M-22.00M-40.25M-17.89M-31.86M-26.07M-43.75M
Net Cash Flow (Quarter)
-17.93M23.03M-33.12M19.29M34.67M71.88M-57.41M-18.10M6.14M-51.17M-4.32M-6.45M108.54M-113.54M40.64M16.96M29.83M-83.67M2.01M7.47M